MedTrace Logo

Posterior Nasal Nerve (PNN) Rhinitis Study

NCT03727347 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 50

Last updated 2021-06-16

Study results available
· View outcomes & findings →

Summary

Evaluation of the Aerin Medical Device used for the treatment of chronic rhinitis

Conditions

  • Chronic Rhinitis

Interventions

DEVICE

InSeca Stylus

Low power radiofrequency energy delivery to the portion of the nasal cavity mucosa overlying the region of the posterior nasal nerve (the posterior middle meatus and posterior inferior meatus).

Sponsors & Collaborators

  • Aerin Medical

    lead INDUSTRY

Principal Investigators

  • V. Vasu Kakarlapudi, MD · Advanced ENT and Allergy, New Albany, IN

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
22 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2018-10-16
Primary Completion
2020-02-01
Completion
2020-09-17
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03727347 on ClinicalTrials.gov